2 results match your criteria: "Dubai Health Authority Thalassemia Center[Affiliation]"
Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis.
Am J Hematol
April 2019
Department of Haematology, University College London, London, United Kingdom.
Prevalence of iron overload complications among patients with b-thalassemia major treated at Dubai Thalassemia Centre.
Ann Saudi Med
September 2013
Dubai Health Authority Thalassemia Center, Dubai, United Arab Emirates.
Background And Objectives: Authors and team members of the Dubai Thalassemia Centre obtained data on the prevalence of iron overload complications among patients with b-thalassemia major (b-TM) and compared it to international data to improve patient care and evaluate the effectiveness of earlier used treatment modalities. The information obtained is also expected to be useful in genetic counseling.
Design And Setting: Cross-sectional study of all living transfusion-dependent b-TM patients registered at the Thalassemia Centre in Dubai, United Arab Emirates, until the end of 2007 (n=382).